MedTrace Logo

Comparison Between Diode Laser and Bleomycin in Treatment of Hemangioma

NCT06510829 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2024-07-19

No results posted yet for this study

Summary

Assessment of the Effectiveness of Bleomycin Intralesional Injection and Diode Laser on Management of Infantile Hemangioma., with regard to :

* Clinically based on Change in the Size and Color of Hemangioma.
* Ultrasonography considering Vascularity ,Echogenicity , Height , and Morphology .
* Comparison of Complications associated with Bleomycin and Diode Laser.

Conditions

  • Bleomycin Adverse Reaction

Interventions

DEVICE

Diode laser

Application of laser waves on the lesion

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
3 Months
Max Age
12 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2026-09-30
Completion
2026-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06510829 on ClinicalTrials.gov